RU106521U1 - EMBRYO IMPLANTER - Google Patents

Abstract

 1. The embryo implant is made up of a container with a compressed sterile air mixture and a disposable sterile plastic uterine tip, which is designed to fit on the cylinder head, and in the distal part of the uterine tip there is a protective mesh-divider, made with the possibility of preventing the direct air stream. ! 2. The embryo implant according to claim 1, characterized in that the composition of the air mixture in the balloon is selected from a ratio of 89% oxygen and 11% nitrogen.

Description

Application area

The utility model relates to auxiliary tools in medicine and can be used to increase the possibility of implantation of embryos in the uterine mucosa during the artificial insemination (IVF) procedure.

State of the art

Currently, more and more women suffer from infertility, due to many reasons - untimely treatment of gynecological diseases, hereditary factors, genetic abnormalities, poor living and nutrition conditions, underdevelopment of the uterine body, adhesions in the pelvic cavity, etc.

One of the methods for treating infertility is the currently widely used method of in vitro fertilization (IVF) [1-7].

In vitro fertilization is fertilization outside the human body. After the ovulation stimulation is carried out, one or several eggs are obtained by puncture, which are fertilized with sperm in the laboratory, followed by transfer of the resulting embryos to the uterine cavity of the woman. The prior art method of in vitro fertilization (patent RU 2181581), including ovulation stimulation, controlled by ultrasound and hormonal testing, in vitro fertilization and transfer of embryos into the uterine cavity, characterized in that the location of the dominant ovary is determined by the U3 method, percutaneous stimulation of the BM-147 reflex point zone on the same side, after which the woman is placed on the corresponding side and the embryos are transferred into the uterine cavity on side of the endometrium, ipsilateral dominant ovary. Also known from the prior art is a method of in vitro fertilization (patent RU 2190978) by preliminary induction of superovulation and transfer of embryos into the uterine cavity, characterized in that at the time of follicular puncture, separate preovulatory oocytes and follicular fluid from the right and left ovaries are separately aspirated, determined in the activity of proteolytic enzymes - acid peptide-hydrolases and transfer of embryos into the uterine cavity is carried out on the side of the endometrium, ipsilateral to the ovary, where the activity of the peptide hydrolase exceeded by 20 mg / ml for 1 h or more the corresponding indicator of another ovary.

The transfer of embryos into the uterine cavity takes place on a gynecological chair with a special plastic catheter, without expanding the cervix and other traumatic manipulations (see solutions WO 9937348, US 6010448, US 6610005, WO 2009104093, US 2009299129; these methods are selected as prototypes). After embryo transfer, the woman is in the clinic for 3 hours and then, with the successful pregnancy, she continues to be observed by the doctor. All stages of artificial insemination - stimulation of the ovaries, ovarian puncture, embryological selection of the obtained eggs, joint cultivation of eggs and sperm in the laboratory for fertilization and development of the embryo, transfer of embryos into the uterine cavity are under the direct supervision of a doctor. However, after the embryos are transferred to the uterine cavity of the woman, the process of implantation (engraftment) of fertilized eggs to the endometrium is not controlled and does not respond to the manipulations of the doctor. In this regard, the possibility of successful implantation is 5-7%, which, of course, is very small.

The technical result of this utility model is to increase the possibility of successful implantation of the embryo to the endometrium with its subsequent development. Those. provides improved "adhesion" of the embryo transferred to the uterine cavity with pre-caecum endometrium, which is a very important point in the process of in vitro fertilization.

Utility Model Implementation

The claimed technical result of improving blastocyst implantation to the endometrium is achieved by creating air pressure in the uterine body cavity, due to this the closest contact and fusion of the blastocyst with the endometrium and subsequent implantation are carried out.

The embryo implant is made up of a container with a compressed sterile air mixture and a disposable sterile plastic uterine tip, which is designed to fit onto the cylinder head, and in the distal part of the uterine tip there is a protective mesh-divider, made with the possibility of preventing the direct air stream.

The composition of the air mixture is selected from a ratio of 89% oxygen and 11% nitrogen.

Brief Description of the Drawings

Figure 1 shows the structural device of the embryo implant (side view) (a) the device of a disposable sterile plastic tip (b), for introducing the air mixture into the cervix, where 1 is a balloon with a compressed sterile air mixture (composition: 89% oxygen + 11 % nitrogen), designed for 1-2 injections (under a pressure of 1 atmosphere), 2 - a plastic tip for spraying an air stream, 3 - a protective mesh-divider, which looks like a cap fixed on the distal part of the uterine tip, 4 - a lever for discharging the mixture from a cylinder, 5 - con q, pushed onto the spout balloon 6 - end having a conical extension is pressed against the outer opening of the cervical canal of the cervix, 7 - the hole in the conical end-8- tubes dividers jets air mixture in a protective grid.

Figure 2 shows the position of the embryo in the uterine cavity after administration through the catheter, where 9 are the mucous membranes of the uterus, 10 is the embryo.

Figure 3 shows the input of the tip of the implant into the uterine cavity through the cervix and injection of the air mixture, where 11 is the cervix.

Utility Model Implementation

The embryo implant (Figure 1) consists of a balloon (1) with compressed sterile air (composition: 89% oxygen + 11% nitrogen), designed for 1-2 air injections into the uterine cavity. A special disposable sterile plastic uterine tip (2) is attached to the cylinder, which is mounted on the cylinder head with a tubular end (5). On the distal part of the uterine tip there is a protective mesh-divider (3), which prevents a direct stream of air from entering the uterine cavity and helps to create uniform pressure in the uterine cavity. The composition of the air mixture is selected empirically from a ratio of 89% oxygen and 11% nitrogen. This composition of the mixture provides the most comfortable conditions for the development of the embryo.

However, the percentage of the mixture may be different. This does not have a significant effect on the embryo.

The principle of operation of the device is as follows.

After successful in vitro fertilization and transfer of embryos into the uterine cavity (Figure 2), the implant tip (2) is inserted into the uterus through the cervix (11), pressing against the outer opening of the cervical canal of the cervix with a conical tip (6), which helps keep the air mixture from escaping it through the cervix (11) and ensures the formation of air pressure in the uterine cavity. Then, acting on the lever (4), the air mixture is injected from the balloon (1) through the tip (2) into the uterine cavity (Figure 3), where it is evenly distributed through the mesh-divider (3) and creates air pressure, which contributes to that the embryo is slightly pressed against the mucous cavity (9) of the uterus and is more successfully fixed on the mucosa.

Since the pressure in the uterine cavity (see Figure 3) promotes closer adhesion of the embryo (10) to the mucous cavity (9) of the uterus, this allows a higher probability of implantation of the embryo and a better end result in the process of artificial insemination (IVF).

The mucous membrane of the endometrium (9) of the uterine cavity, to which the blastocyst is implanted in women of the reproductive period, consists of 2 layers: the basal, 1-1.5 cm thick, located on the inner layer of the myometrium and the functional layer, the thickness of which varies from day to day menstrual cycle from 1 mm to 8 mm. In the phase of secretion, under the influence of edema of the endometrium, the argyrophilic fibers of the reticular fibrous structure of the endometrium move apart and are densely located around the vessels and glands. Under normal conditions, branching of the glands does not occur, but in the phase of secretion in the functional layer, a deep spongy layer forms, where the glands are more closely located and the surface compact layer, in which the cytogenic stroma predominates. The surface epithelium in the proliferation phase is functionally and morphologically similar to the glandular epithelium. But with the onset of the secretion phase, changes occur in it that contribute to easier adhesion of the blastocyst with the endometrium and subsequent implantation and development of the embryo. The most vulnerable stage of the in vitro fertilization (IVF) program at the moment is the period of transfer of the embryo into the uterine cavity with its subsequent implantation (see [1-7] and Figure 2). The reasons for the impossibility of implanting embryos are numerous (from fetal abnormalities to endometrial abnormalities) and are described in scientific papers of various authors [1–7], but no one notes such an important factor as the initial close mechanical adhesion of the blastocyst with endometrium and its subsequent implantation.

Successful in vitro fertilization and transfer of embryos into the uterine cavity does not always end with the onset of a desired pregnancy (successful result from 4 to 15%). And, of course, one of the many factors of failure may be the absence at the initial stage of close contact of the implantable embryo with the pre-caecum endometrium.

This device solves the problem of closer adhesion of the embryo to the endometrium.

Information sources:

1. Khondrikov N.I. (1989) Biopsy in gynecological practice. Obstetrics and Gynecology, 4; 68-74

2. Nakajima ST., Molley M.N., Oi R.H., Ohlson K.A., Arevedo S.A., Boyers S.P. (1994) Clinical evaluation of luteal function. Obstetrics # Gynecology 84 (2); 219-221

3. Bonhoff A., Naether O., Johannison E., Bohnet H.J. (1993) Morphometric characteristics of endometrial biopsies after different types of ovarion stimulation for infertility treatment. Fertility # Sterility, 59 (3); 560-566

4. Nikitin A.I. Failure factors in an assisted reproduction program. Problems of reproduction, 1995. - No. 2. - p. 36-43

5. Klentzoris L.D., Li T. S., Doekeryet A. Endometrial morphology: a predictive factor of pregnancy rate in infertile women. Hum. Reprat. - 1990. - Suppl. 1. - p. 52-66

6. Anshina M.B., Zdanovsky B.M. If you need a baby. M., 1998, 32 p.

7. In vitro fertilization and its new directions in the treatment of female infertility (theoretical and practical approaches): A guide for doctors / Edited by V.I. Kulakova, B.I. Leonova - M., 2001, 782 p.

Claims (2)

1. The embryo implant is made up of a container with a compressed sterile air mixture and a disposable sterile plastic uterine tip, which is designed to fit on the cylinder head, and in the distal part of the uterine tip there is a protective mesh-divider, made with the possibility of preventing the direct air stream. 2. The embryo implant according to claim 1, characterized in that the composition of the air mixture in the balloon is selected from a ratio of 89% oxygen and 11% nitrogen.